MedTrace Logo

The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer

NCT05752812 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2023-10-27

No results posted yet for this study

Summary

The goal of this observational study is to validate a pretreatment prognostic score (Heidelberg Prognostic Pancreatic Cancer Score - HELPP) in patients with pancreatic ductal adenocarcinoma.

The main questions it aims to answer are:

* Is the HELPP score able to predict median overall survival in a prospective multi-institutional cohort of patients with pretherapeutic localized non-metastatic pancreatic cancer?
* Is the HELPP score able to predict median recurrence-free survival and patterns of recurrence after resection of pancreatic cancer?

Conditions

  • Pancreatic Adenocarcinoma

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Oliver Strobel, MD MBA · Medical University Vienna

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2026-05-31
Completion
2026-11-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05752812 on ClinicalTrials.gov